Alpha Teknova (TKNO) Interest & Investment Income (2020 - 2021)

Alpha Teknova's (TKNO) quarterly Interest & Investment Income came in at -$304000.0 in Q2 2021, down 1421.74% year-on-year from $23000.0 in Q2 2020, and down 1421.74% on a QoQ basis from $23000.0 in Q2 2020.

Alpha Teknova (TKNO) Interest & Investment Income (2020 - 2021) Analysis & Trends

Alpha Teknova (TKNO) has 2 years of Interest & Investment Income data on file, last reported at -$304000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Alpha Teknova 258.92 Mn 241.13 Mn 3.78 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 -304,000.00
Jun 30, 2020 23,000.00